Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug

The purpose of this study was to develop an oral proliposomal powder of protein using poly-<span style="font-variant: small-caps;">l</span>-arginine-conjugated 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) (DSPE-PEG) (PLD) for enhancing cellular associat...

Full description

Saved in:
Bibliographic Details
Main Authors: Amolnat Tunsirikongkon (Author), Yong-Chul Pyo (Author), Dong-Hyun Kim (Author), Sang-Eun Lee (Author), Jeong-Sook Park (Author)
Format: Book
Published: MDPI AG, 2019-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a7dfdbc09f014feeb8a76d4dee1e67e8
042 |a dc 
100 1 0 |a Amolnat Tunsirikongkon  |e author 
700 1 0 |a Yong-Chul Pyo  |e author 
700 1 0 |a Dong-Hyun Kim  |e author 
700 1 0 |a Sang-Eun Lee  |e author 
700 1 0 |a Jeong-Sook Park  |e author 
245 0 0 |a Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug 
260 |b MDPI AG,   |c 2019-06-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics11060272 
520 |a The purpose of this study was to develop an oral proliposomal powder of protein using poly-<span style="font-variant: small-caps;">l</span>-arginine-conjugated 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) (DSPE-PEG) (PLD) for enhancing cellular association upon reconstitution and to compare its effects with a non-grafted and PEGylated formulation. Cationic proliposome (CATL), PLD-grafted CATL (PLD-CATL), PEGylated CATL (PEG CATL), and PLD grafted-PEG CATL (PLD-PEG CATL) were prepared and compared. Successful conjugation between poly-<span style="font-variant: small-caps;">l</span>-arginine and DSPE-PEG was confirmed by <sup>1</sup>H NMR and FT-IR. PLD was successfully grafted onto the proliposomal powder during the slurry process. Although reconstituted liposomal sizes of CATL and PLD-CATL were increased by agglomeration, PEGylation reduced the agglomeration and increased the encapsulation. The viabilities of cells treated with both CATL and PLD-CATL formulations were low but increased following PEGylation. With regard to cellular association, PLD-CATL enhanced cellular association/uptake more rapidly than did CATL. Upon PEGylation, PEG CATL showed a lower level of cellular association/uptake compared with CATL while PLD-PEG CATL did not exhibit the rapid cellular association/uptake as seen with PLD-CATL. However, PLD-PEG CATL still enhanced the higher cellular association/uptake than PEG CATL did without PLD. In conclusion, proliposomes with PLD could accelerate cellular association/uptake but also caused high cellular toxicity. PEGylation reduced cellular toxicity and also changed the cellular association pattern of the PLD formulation. 
546 |a EN 
690 |a poly-<span style="font-variant: small-caps">l</span>-arginine 
690 |a DSPE-PEG 
690 |a cationic proliposome 
690 |a cellular association 
690 |a cytotoxicity 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 11, Iss 6, p 272 (2019) 
787 0 |n https://www.mdpi.com/1999-4923/11/6/272 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/a7dfdbc09f014feeb8a76d4dee1e67e8  |z Connect to this object online.